A clinical trial update dated June 2, 2026 reports that a study involving nafarelin is currently recruiting. The trial, registered as NCT07620067 and titled "GnRH for Luteal Support - Mechanism of Action," is examining nafarelin, an approved compound.
The study's current status is listed as recruiting. No phase information was provided in this update. No results or outcome data have been posted for this trial at this time.
This update reflects only the recruitment status and title as recorded in the trial registry entry as of the stated date. Further details about the trial's design, objectives, or eventual findings are not included in this update and should be sought directly from the official registry listing.
Readers interested in learning more about nafarelin, including its approved regulatory status and general background, can consult the compound overview for additional context.